JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evoniuk, G.
Right arrow Articles by Wurtman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evoniuk, G.
Right arrow Articles by Wurtman, R. J.

Antagonism of the cardiovascular effects of adenosine by caffeine or 8- (p-sulfophenyl)theophylline

G Evoniuk, RW von Borstel and RJ Wurtman

We compared the abilities of the adenosine antagonists caffeine and 8- (p-sulfophenyl)theophylline (8-SPT) to block adenosine receptor- mediated hypotension and bradycardia in anesthetized rats. Few quantitative data exist concerning the amounts of caffeine needed to prevent the cardiovascular effects of physiologic plasma adenosine concentrations or concerning the site of action (central or peripheral) of such blockade. Thus, dose-response curves were constructed for the antagonism by caffeine or 8-SPT of the hypotension and bradycardia caused by infusing adenosine i.v. or by giving bolus i.v. injections of the adenosine analogs 2-chloroadenosine, R-phenylisopropyladenosine or N-ethylcarboxamidoadenosine. We also quantitated the suppression by caffeine or 8-SPT of the ability of adenosine to potentiate nicotine- induced hypertension and tachycardia. Caffeine (EC50 = 92 microM) and 8- SPT (EC50 = 48 microM) blocked the hypotension produced by elevating plasma adenosine levels from 1.22 to 1.74 microM. Similar drug doses were needed to inhibit the potentiation by adenosine of pressor and chronotropic responses to nicotine or to antagonize the hypotensive and negative chronotropic effects of 2-chloroadenosine, R- phenylisopropyladenosine and N-ethylcarboxamidoadenosine. As expected, neither caffeine nor 8-SPT demonstrated selectivity for A1 (predominating at the heart) vs. A2 (predominating at blood vessels) receptor subtypes. Administration of as much as 50 mg/kg i.p. of 8-SPT failed to produce detectable brain levels of the drug, demonstrating its failure to gain access to the central nervous system and indicating that the site at which the drug antagonizes the cardiovascular effects of adenosine is peripheral.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 240, Issue 2, pp. 428-432, 02/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Hart, D. Kohler, T. Eckle, D. Kloor, G. L. Stahl, and H. K. Eltzschig
Direct Treatment of Mouse or Human Blood With Soluble 5'-Nucleotidase Inhibits Platelet Aggregation
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1477 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Swoap, M. Rathvon, and M. Gutilla
AMP does not induce torpor
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R468 - R473.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. P. Walsh and J. M. Marshall
The role of adenosine in the early respiratory and cardiovascular changes evoked by chronic hypoxia in the rat
J. Physiol., August 15, 2006; 575(1): 277 - 289.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M.R. Zarrindast and M.R. Heidari
Involvement of adenosine receptors in mouse thermoregulation
J Psychopharmacol, January 1, 1993; 7(4): 365 - 370.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.